Govt fast-tracks approval for foreign-produced COVID-19 vaccines cleared in other countries

By: |
April 13, 2021 3:24 PM

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunization programme within the country, the Union Health Ministry said.

covid 19 vaccine, covid 19 pandemicFurthermore, 2,94,660 vaccine doses are in the pipeline and will be received by the states within the next three days, it said. (Representational image: IE)

With an aim to expand the basket of COVID-19 vaccines and enhance the pace of inoculation in India, the central government on Tuesday said it has fast-tracked emergency approval for foreign-produced jabs that have been granted similar clearances in other countries.

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunization programme within the country, the Union Health Ministry said.

The Centre’s decision came after an expert panel recommended that COVID-19 vaccines which have been developed and are being manufactured in foreign countries and which have been granted emergency approval for restricted use by authorities in the US, Europe, the UK, Japan or which are listed in the WHO Emergency Use Listing may be granted emergency use approval in India.

The expert panel also mandated the requirement of post-approval parallel bridging clinical trial in place of conduct of local clinical trial.

“This decision will facilitate quicker access to such foreign vaccines by India and would encourage imports including import of bulk drug material, optimal utilization of domestic fill and finish capacity, etc., which will in turn provide a fillip to vaccine manufacturing capacity and total vaccine availability for domestic (use),” the ministry said.

Currently, two vaccines — Covaxin by Bharat Biotech and Covishield by Serum Institute of India (SII) — are being used for inoculation in India.

India’s drug regulator has also granted permission for the restricted emergency use of the Russian COVID-19 vaccine Sputnik V with certain conditions on Monday.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus did leak from China’s Wuhan Institute of Virology, claims explosive report by US Republicans
2Department of physiotherapy at DPSRU launches pediatrics physiotherapy unit
3Over 3.14 crore Covid vaccine doses available with states, UTs and pvt hospitals: Govt